Carbohydrate-dependent defense mechanism against Helicobacter pylori infection

Current Drug Metabolism

Volumn 10, Issue 1, 2009, Pages 29-40

  Kobayashi, Motohiro ^a   Lee, Heeseob ^b   Nakayama, Jun ^a   Fukuda, Minoru ^c  

^a SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Pusan National University   (South Korea)

^c BURNHAM INSTITUTE   (United States)

Author keywords

1; 4 GlcNAc capped O glycan; 6 sulfo sialyl Lewis X capped O glycan; Adhesin; Cholesterol glucosyltransferase; Cholestery1 D glucopyranoside; Helicobacter pylori; Lewis blood group antigen; Lipopolysaccharide

Indexed keywords

ADDRESSIN; ADHESIN; ALPHA 1,4 N ACETYLGLUCOSAMINE CAPPED O GLYCAN; BACTERIUM LIPOPOLYSACCHARIDE; CAGA PROTEIN; CARBOHYDRATE ANTIGEN; CHOLESTEROL ALPHA GLUCOSYLTRANSFERASE; CHOLESTERYL ALPHA DEXTRO GLUCOPYRANOSIDE; CORE PROTEIN; GLUCOPYRANOSIDE; GLUCOSYLTRANSFERASE; N ACETYLGLUCOSAMINE; NONSTEROID ANTIINFLAMMATORY AGENT; O ANTIGEN; PERIPHERAL LYMPH NODE ADDRESSIN; PROTEIN BABA; PROTEIN SABA; SIALOADHESIN; SIALYL LEWIS X ANTIGEN; UNCLASSIFIED DRUG; VACUOLATING TOXIN; HP0421 PROTEIN, HELICOBACTER PYLORI; L SELECTIN COUNTER RECEPTORS; L-SELECTIN COUNTER-RECEPTORS; MEMBRANE ANTIGEN; MEMBRANE PROTEIN; POLYSACCHARIDE;

ANTIBACTERIAL ACTIVITY; ANTIGEN EXPRESSION; BACTERIAL CELL WALL; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIAL VIABILITY; BACTERIAL VIRULENCE; BLOOD GROUP LEWIS SYSTEM; CELL ADHESION; CHRONIC GASTRITIS; DRUG DETERMINATION; ENZYME INHIBITION; EPITHELIUM CELL; GASTRITIS; GENE EXPRESSION; GRAM NEGATIVE AEROBIC RODS AND COCCI; GROWTH INHIBITION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGICAL TOLERANCE; INFLAMMATORY INFILTRATE; MOLECULAR CLONING; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NONHUMAN; PATHOGENESIS; PEPTIC ULCER; PREVALENCE; PROTEIN EXPRESSION; REVIEW; STOMACH ADENOCARCINOMA; STOMACH EPITHELIUM; VENULE; DRUG ANTAGONISM; GASTROINTESTINAL DISEASE; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; STOMACH MUCOSA;

ANTIGENS, SURFACE; GASTRIC MUCOSA; GASTROINTESTINAL DISEASES; GLUCOSYLTRANSFERASES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MEMBRANE PROTEINS; POLYSACCHARIDES;

EID: 62749092134     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920009787048428     Document Type: Review

References (102)

1. Doenges, J.L. Spirochaetes in gastric glands of macacus rhesus and humans without definite history of related disease. Proc. Soc. Exp. Biol. Med., 1938, 38, 536-538.
2. Freedburg, A.S.; Barron, L.E. The presence of spirochaetes in human gastric mucosa. Am. J. Dig. Dis., 1940, 7, 443-445.
3. Warren, J.R.; Marshall, B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet, 1983, 321(8336), 1273-1275.
4. Marshall, B.J.; Warren, J.R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet, 1984, 323(8390), 1311-1315.
5. Marshall, B.J.; Armstrong, J.A.; McGechie, D.B.; Glancy, R.J. Attempt to fulfil Koch's postulates for pyloric Campylobacter Med. J. Aust., 1985, 142(8), 436-439.
6. Megraud, F. A humble bacterium sweeps this year's Nobel Prize. Cell, 2005, 123(6), 975-976.
7. Liu, C.; Crawford, J.M. In Robbins and Cortran Pathologic Basis of Disease, 7th ed.; Kumar, V.; Abbas, A.K.; Fausto, N., Eds.; Elsevier Saunders: Philadelphia, 2005; pp. 797-875.
8. Suzuki, H.; Mori, M.; Seto, K.; Miyazawa, M.; Kai, A.; Suematsu, M.; Yoneta, T.; Miura, S.; Ishii, H. Polaprezinc attenuates the Helicobacter pylori-induced gastric mucosal leucocyte activation in Mongolian gerbils - a study using intravital videomicroscopy. Aliment Pharmacol. Ther., 2001, 15(5), 715-725.
9. The EUROGAST Study Group. Epidemiology of, and risk factors for, Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. Gut, 1993, 34(12), 1672-1676.
10. Hopkins, R.J.; Russell, R.G.; O'Donnoghue, J.M.; Wasserman, S.S.; Lefkowitz, A.; Morris, J.G., Jr. Seroprevalence of Helicobacter pylori in Seventh-Day Adventists and other groups in Maryland. Lack of association with diet. Arch. Intern. Med., 1990, 150(11), 2347-2348.
11. Farinha, P.; Gascoyne, R.D. Helicobacter pylori and MALT lymphoma. Gastroenterology, 2005, 128(6), 1579-1605.
12. Parsonnet, J.; Blaser, M.J.; Perez-Perez, G.I.; Hargrett-Bean, N.; Tauxe, R.V. Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists. Gastroenterolgy, 1992, 102(1), 41-46.
13. Banatvala, N.; Mayo, K.; Megraud, F.; Jennings, R.; Deeks, J.J.; Feldman, R.A. The cohort effect and Helicobacter pylori. J. Infect. Dis., 1993, 168(1), 219-221.
14. Cullen, D.J.; Collins, B.J.; Christiansen, K.J.; Epis, J.; Warren, J.R.; Surveyor, I.; Cullen, K.J. When is Helicobacter pylori infection acquired? Gut, 1993, 34(12), 1681-1682.
15. Kumagai, T.; Malaty, H.M.; Graham, D.Y.; Hosogaya, S.; Misawa, K.; Furihata, K.; Ota, H.; Sei, C.; Tanaka, E.; Akamatsu, T.; Shimizu, T.; Kiyosawa, K.; Katsuyama, T. Acquisition versus loss of Helicobacter pylori infection in Japan: results from an 8-year birth cohort study. J. Infect. Dis., 1998, 178(3), 717-721.
16. Everhart, J.E. Recent developments in the epidemiology of Helicobacter pylori. Gastroenterol. Clin. North Am., 2000, 29(3), 559-578.
17. Covacci, A.; Telford, J.L.; Del Giudice, G.; Parsonnet, J.; Rappuoli, R. Helicobacter pylori virulence and genetic geography. Science, 1999, 284(5418), 1328-1333.
18. Sipponen, P.; Hyvarinen, H. Role of Helicobacter pylori in the pathogenesis of gastritis, peptic ulcer and gastric cancer. Scand. J. Gastroenterol. Suppl., 1993, 196, 3-6.
19. Sipponen, P.; Kekki, M.; Haapakoski, J.; Ihamaki, T.; Siurala, M. Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int. J. Cancer, 1985, 35(2), 173-177.
20. Reis, C.A.; David, L.; Correa, P.; Carneiro, F.; de Bolos, C.; Garcia, E.; Mandel, U.; Clausen, H.; Sobrinho-Simoes, M. Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res., 1999, 59(5), 1003-1007.
21. Reis, C.A.; David, L.; Nielsen, P.A.; Clausen, H.; Mirgorodskaya, K.; Ro epstorff, P.; Sobrinho-Simoes, M. Immunohistochemical study of MUC5AC expression in human gastric carcinomas using a novel monoclonal antibody. Int. J. Cancer, 1997, 74(1), 112-121.
22. Parkin, D.M. Global cancer statistics in the year 2000. Lancet Oncol., 2001, 2(9), 533-543.
23. Lauren, P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol. Microbiol. Scand., 1965, 64, 31-49.
24. Sipponen, P.; Marshall, B.J. Gastritis and gastric cancer. Western countries. Gastroenterol. Clin. North Am., 2000, 29(3), 579-592.
25. Isaacson, P.; Wright, D.H. Extranodal malignant lymphoma arising from mucosa-associated lymphoid tissue. Cancer, 1984, 53(11), 2515-2524.
26. Kumar, V.; Abbas, A.; Fausto, N. In Robbins and Cortran Pathologic Basis of Disease, 7th ed.; Kumar, V.; Abbas, A.; Fausto, N., Eds.; Elsevier Saunders: Philadelphia, 2005; pp. 269-342.
27. Covacci, A.; Censini, S.; Bugnoli, M.; Petracca, R.; Burroni, D.; Macchia, G.; Massone, A.; Papini, E.; Xiang, Z.; Figura, N.; Rappuoli, R. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc. Natl. Acad. Sci. U. S. A., 1993, 90(12), 5791-5795.
28. Tomb, J.F.; White, O.; Kerlavage, A.R.; Clayton, R.A.; Sutton, G.G.; Fleischmann, R.D.; Ketchum, K.A.; Klenk, H.P.; Gill, S.; Dougherty, B.A.; Nelson, K.; Quackenbush, J.; Zhou, L.; Kirkness, E.F.; Peterson, S.; Loftus, B.; Richardson, D.; Dodson, R.; Khalak, H.G.; Glodek, A.; McKenney, K.; Fitzegerald, L.M.; Lee, N.; Adams, M.D.; Hickey, E.K.; Berg, D.E.; Gocayne, J.D.; Utterback, T.R.; Peterson, J.D.; Kelley, J.M.; Cotton, M.D.; Weidman, J.M.; Fujii, C.; Bowman, C.; Watthey, L.; Wallin, E.; Hayes, W.S.; Borodovsky, M.; Karp, P.D.; Smith, H.O.; Fraser, C.M.; Venter, J.C. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature, 1997, 388(6642), 539-547.
29. Alm, R.A.; Ling, L.S.; Moir, D.T.; King, B.L.; Brown, E.D.; Doig, P.C.; Smith, D.R.; Noonan, B.; Guild, B.C.; deJonge, B.L.; Carmel, G.; Tummino, P.J.; Caruso, A.; Uria-Nickelsen, M.; Mills, D.M.; Ives, C.; Gibson, R.; Merberg, D.; Mills, S.D.; Jiang, Q.; Taylor, D.E.; Vovis, G.F.; Trust, T.J. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature, 1999, 397(6715), 176-180.
30. Segal, E.D.; Cha, J.; Lo, J.; Falkow, S.; Tompkins, L.S. Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. Proc. Natl. Acad. Sci. U. S. A., 1999, 96(25), 14559-14564.
31. Asahi, M.; Azuma, T.; Ito, S.; Ito, Y.; Suto, H.; Nagai, Y.; Tsubokawa, M.; Tohyama, Y.; Maeda, S.; Omata, M.; Suzuki, T.; Sasakawa, C. Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells. J. Exp. Med., 2000, 191(4), 593-602.
32. Odenbreit, S.; Puls, J.; Sedlmaier, B.; Gerland, E.; Fischer, W.; Haas, R. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science, 2000, 287(5457);1497-1500.
33. Stein, M.; Rappuoli, R.; Covacci, A. Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation. Proc. Natl. Acad. Sci. U. S. A., 2000, 97(3), 1263-1268.
34. Higashi, H.; Tsutsumi, R.; Muto, S.; Sugiyama, T.; Azuma, T.; Asaka, M.; Hatakeyama, M. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science, 2002, 295(5555), 683-686.
35. Ohnishi, N.; Yuasa, H.; Tanaka, S.; Sawa, H.; Miura, M.; Matsui, A.; Higashi, H.; Musashi, M.; Iwabuchi, K.; Suzuki, M.; Yamada, G.; Azuma, T.; Hatakeyama, M. Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc. Natl. Acad. Sci. U. S. A., 2008, 105(3), 1003-1008.
36. Saadat, I.; Higashi, H.; Obuse, C.; Umeda, M.; Murata-Kamiya, N.; Saito, Y.; Lu, H.; Ohnishi, N.; Azuma, T.; Suzuki, A.; Ohno, S.; Hatakeyama, M. Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature, 2007, 447(7142), 330-333.
37. Togayachi, A.; Akashima, T.; Ookubo, R.; Kudo, T.; Nishihara, S.; Iwasaki, H.; Natsume, A.; Mio, H.; Inokuchi, J.; Irimura, T.; Sasaki, K.; Narimatsu, H. Molecular cloning and characterization of UDP-GlcNAc:lactosylceramide β1,3-N-acetylglucosaminyltransferase (β3Gn-T5), an essential enzyme for the expression of HNK1 and Lewis X epitopes on glycolipids. J Biol. Chem., 2001, 276(25), 22032-22040.
38. Marcos, N.T.; Magalhaes, A.; Ferreira, B.; Oliveira, M.J.; Carvalho, A.S.; Mendes, N.; Gilmartin, T.; Head, S.R.; Figueiredo, C.; David, L.; Santos-Silva, F.; Reis, C.A. Helicobacter pylori induces β3GnT5 in human gastric cell lines, modulating expression of the SabA ligand sialyl Lewis x. J. Clin. Invest., 2008, 118(6), 2325-2336.
39. Cover, T.L.; Blaser, M.J. Purification and characterization of the vacuolating toxin from Helicobacter pylori. J. Biol. Chem., 1992, 267(15), 10570-10575.
40. Catrenich, C.E.; Chestnut, M.H. Character and origin of vacuoles induced in mammalian cells by the cytotoxin of Helicobacter pylori. J. Med. Microbiol., 1992, 37(6), 389-395.
41. Papini, E.; Bugnoli, M.; De Bernard, M.; Figura, N.; Rappuoli, R.; Montecucco, C. Bafilomycin A1 inhibits Helicobacter p ylori-induced vacuolization of HeLa cells. Mol. Microbiol., 1993, 7(2), 323-327.
42. Papini, E.; Zoratti, M.; Cover, T.L. In search of the Helicobacter pylori VacA mechanism of action. Toxicon, 2001, 39(11), 1757-1767.
43. Czajkowsky, D.M.; Iwamoto, H.; Cover, T.L.; Shao, Z. The vacuolating toxin from Helicobacter p ylori forms hexameric pores in lipid bilayers at low pH. Proc. Natl. Acad. Sci. USA, 1999, 96(5), 2001-2006.
44. Szabo, I.; Brutsche, S.; Tombola, F.; Moschioni, M.; Satin, B.; Telford, J.L.; Rappuoli, R.; Montecucco, C.; Papini, E.; Zoratti, M. Formation of anion-selective channels in the cell plasma membrane by the toxin VacA of Helicobacter p ylori is required for its biological activity. EMBO J., 1999, 18(20), 5517-5527.
45. Tombola, F.; Carlesso, C.; Szabo, I.; de Bernard, M.; Reyrat, J.M.; Telford, J.L.; Rappuoli, R.; Montecucco, C.; Papini, E.; Zoratti, M. Helicobacter pylori vacuolating toxin forms anion-selective channels in planar lipid bilayers: possible implications for the mechanism of cellular vacuolation. Biophys. J., 1999, 76(3), 1401-1409.
46. Schraw, W.; Li, Y.; McClain, M.S.; van der Goot, F.G.; Cover, T.L. Association of Helicobacter pylori vacuolating toxin (VacA) with lipid rafts. J. Biol. Chem., 2002, 277(37), 34642-34650.
47. Willhite, D.C.; Cover, T.L.; Blanke S.R. Cellular vacuolation and mitochondrial cytochrome c release are independent outcomes of Helicobacter pylori vacuolating cytotoxin activity that are each dependent on membrane channel formation. J. Biol. Chem., 2003, 278(48), 48204-48209.
48. Galmiche, A.; Rassow, J.; Doye, A.; Cagnol, S.; Chambard, J.C.; Contamin, S.; de Thillot, V.; Just, I.; Ricci, V.; Solcia, E.; Van Obberghen, E.; Boquet, P. The N-terminal 34 kDa fragment of Helicobacter pylori vacuolating cytotoxin targets mitochondria and induces cytochrome c release. EMBO J., 2000, 19(23), 6361-6370.
49. Kuck, D.; Kolmerer, B.; Iking-Konert, C.; Krammer, P.H.; Stremmel, W.; Rudi, J. Vacuolating cytotoxin of Helicobacter pylori induces apoptosis in the human gastric epithelial cell line AGS. Infect. Immun., 2001, 69(8), 5080-5087.
50. Peek, R.M., Jr.; Blaser, M.J.; Mays, D.J.; Forsyth, M.H.; Cover, T.L.; Song, S.Y.; Krishna, U.; Pietenpol, J.A. Helicobacter p ylori strain-specific genotypes and modulation of the gastric epithelial cell cycle. Cancer Res., 1999, 59(24), 6124-6131.
51. Fujikawa, A.; Shirasaka, D.; Yamamoto, S.; Ota, H.; Yahiro, K.; Fukada, M.; Shintani, T.; Wada, A.; Aoyama, N.; Hirayama, T.; Fukamachi, H.; Noda, M. Mice deficient in protein tyrosine phosphatase receptor type Z are resistant to gastric ulcer induction by VacA of Helicobacter pylori. Nat. Genet., 2003, 33(3), 375-381.
52. Gebert, B.; Fischer, W.; Weiss, E.; Hoffmann, R.; Haas, R. Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science, 2003, 301(5636), 1099-1102.
53. McAdam, A.J.; Sharpe, A.H. In Robbins and Cortran Pathologic Basis of Disease, 7th ed.; Kumar, V.; Abbas, A. K.; Fausto, N., Eds.; Elsevier Saunders: Philadelphia, 2005; pp. 343-414.
54. Moran, A.P.; Prendergast, M.M. Molecular mimicry in Campylobacter jejuni and Helicobacter p ylori lipopolysaccharides: contribution of gastrointestinal infections to autoimmunity. J. Autoimmun., 2001, 16(3), 241-256.
55. Moran, A.P. Cell surface characteristics of Helicobacter p ylori. FEMS Immunol. Med. Microbiol., 1995, 10(3-4), 271-280.
56. Amano, K.; Hayashi, S.; Kubota, T.; Fujii, N.; Yokota, S. Reactivities of Lewis antigen monoclonal antibodies with the lipopolysaccharides of Helicobacter pylori strains isolated from patients with gastroduodenal diseases in Japan. Clin. Diagn. Lab. Immunol., 1997, 4(5), 540-544.
57. Wang, G.; Ge, Z.; Rasko, D.A.; Taylor, D.E. Lewis antigens in Helicobacter pylori: biosynthesis and phase variation. Mol. Microbiol., 2000, 36(6), 1187-1196.
58. Appelmelk, B.J.; Monteiro, M.A.; Martin, S.L.; Moran, A.P.; Vandenbroucke-Grauls, C.M. Why Helicobacter pylori has Lewis antigens. Trends Microbiol., 2000, 8(12), 565-570.
59. Aspholm-Hurtig, M.; Dailide, G.; Lahmann, M.; Kalia, A.; Ilver, D.; Roche, N.; Vikstrom, S.; Sjostrom, R.; Linden, S.; Backstrom, A.; Lundberg, C.; Arnqvist, A.; Mahdavi, J.; Nilsson, U.J.; Velapatino, B.; Gilman, R.H.; Gerhard, M.; Alarcon, T.; Lopez-Brea, M.; Nakazawa, T.; Fox, J.G.; Correa, P.; Dominguez-Bello, M.G.; Perez-Perez, G.I.; Blaser, M.J.; Normark, S.; Carlstedt, I.; Oscarson, S.; Teneberg, S.; Berg, D.E.; Boren, T. Functional adaptation of BabA, the H. pylori ABO blood group antigen binding adhesin. Science, 2004, 305(5683), 519-522.
60. Ilver, D.; Arnqvist, A.; Ogren, J.; Frick, I.M.; Kersulyte, D.; Incecik, E.T.; Berg, D.E.; Covacci, A.; Engstrand, L.; Boren, T. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science, 1998, 279(5349), 373-377.
61. Segal, E.D.; Falkow, S.; Tompkins, L.S. Helicobacter pylori attachment to gastric cells induces cytoskeletal rearrangements and tyrosine phosphorylation of host cell proteins. Proc. Natl. Acad. Sci. U. S. A., 1996, 93(3), 1259-1264.
62. Ikehara, Y.; Nishihara, S.; Yasutomi, H.; Kitamura, T.; Matsuo, K.; Shimizu, N.; Inada, K.; Kodera, Y.; Yamamura, Y.; Narimatsu, H.; Hamajima, N.; Tatematsu, M. Polymorphisms of two fucosyltransferase genes (Lewis and Secretor genes) involving type I Lewis antigens are associated with the presence of anti-Helicobacter pylori IgG antibody. Cancer Epidemiol. Biomarkers Prev., 2001, 10(9), 971-977.
63. Gerhard, M.; Lehn, N.; Neumayer, N.; Boren, T.; Rad, R.; Schepp, W.; Miehlke, S.; Classen, M.; Prinz, C. Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc. Natl. Acad. Sci. U. S. A., 1999, 96(22), 12778-12783.
64. Mahdavi, J.; Sonden, B.; Hurtig, M.; Olfat, F.O.; Forsberg, L.; Roche, N.; Angstrom, J.; Larsson, T.; Teneberg, S.; Karlsson, K.A.; Altraja, S.; Wadstrom, T.; Kersulyte, D.; Berg, D.E.; Dubois, A.; Petersson, C.; Magnusson, K.E.; Norberg, T.; Lindh, F.; Lundskog, B.B.; Arnqvist, A.; Hammarstrom, L.; Boren, T. Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science, 2002, 297(5581), 573-578.
65. Rosen, S.D. Ligands for L-selectin: homing, inflammation, and beyond. Annu. Rev. Immunol., 2004, 22, 129-156.
66. von Andrian, U.H.; Mackay, C.R. T-cell function and migration. Two sides of the same coin. N. Engl. J. Med., 2000, 343(14), 1020-1034.
67. Duijvestijn, A.M.; Kerkhove, M.; Bargatze, R.F.; Butcher, E.C. Lymphoid tissue- and inflammation-specific endothelial cell differentiation defined by monoclonal antibodies. J. Immunol., 1987, 138(3), 713-719.
68. Kabel, P.J.; Voorbij, H.A.; de Haan-Meulman, M.; Pals, S.T.; Drexhage, H.A. High endothelial venules present in lymphoid cell accumulations in thyroids affected by autoimmune disease: a study in men and BB rats of functional activity and development. J. Clin. Endocrinol. Metab., 1989, 68(4), 744-751.
69. van Dinther-Janssen, A.C.; Pals, S.T.; Scheper, R.; Breedveld, F.; Meijer, C.J. Dendritic cells and high endothelial venules in the rheumatoid synovial membrane. J. Rheumatol., 1990, 17(1), 11-17.
70. Salmi, M.; Granfors, K.; MacDermott, R.; Jalkanen, S. Aberrant binding of lamina propria lymphocytes to vascular endothelium in inflammatory bowel diseases. Gastroenterology, 1994, 106(3), 596-605.
71. Suzawa, K.; Kobayashi, M.; Sakai, Y.; Hoshino, H.; Watanabe, M.; Harada, O.; Ohtani, H.; Fukuda, M.; Nakayama, J. Preferential induction of peripheral lymph node addressin on high endothelial venule-like vessels in the active phase of ulcerative colitis. Am. J. Gastroenterol., 2007, 102(7), 1499-1509.
72. Streeter, P.R.; Rouse, B.T.; Butcher, E.C. Immunohistologic and functional characterization of a vascular addressin involved in lymphocyte homing into peripheral lymph nodes. J. Cell Biol., 1988, 107(5), 1853-1862.
73. Yeh, J.C.; Hiraoka, N.; Petryniak, B.; Nakayama, J.; Ellies, L.G.; Rabuka, D.; Hindsgaul, O.; Marth, J.D.; Lowe, J.B.; Fukuda, M. Novel sulfated lymphocyte homing receptors and their control by a core1 extension β1,3-N-acetylglucosaminyltransferase. Cell, 2001, 105(7), 957-969.
74. Hemmerich, S.; Leffler, H.; Rosen, S.D. Structure and the Oglycans in GlyCAM-1, an endothelial-derived ligand for L-selectin. J. Biol. Chem., 1995, 270(20), 12035-12047.
75. Kobayashi, M.; Mitoma, J.; Nakamura, N.; Katsuyama, T.; Nakayama, J.; Fukuda, M. Induction of peripheral lymph node addressin in human gastric mucosa infected by Helicobacter pylori. Proc. Natl. Acad. Sci. U. S. A., 2004, 101(51), 17807-17812.
76. Kumamoto, K.; Mitsuoka, C.; Izawa, M.; Kimura, N.; Otsubo N.; Ishida, H.; Kiso, M.; Yamada, T.; Hirohashi, S.; Kannagi, R. Specific detection of sialyl Lewis X determinant carried on the mucin GlcNAcβ1 → 6GalNAcα core structure as a tumor-associated antigen. Biochem. Biophys. Res. Commun., 1998, 247(2), 514-517.
77. Dixon, M.F.; Genta, R.M.; Yardley, J.H.; Correa, P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am. J. Surg. Pathol., 1996, 20(10), 1161-1181.
78. Pablos, J.L.; Santiago, B.; Tsay, D.; Singer, M.S.; Palao, G.; Galindo, M.; Rosen, S.D. A HEV-restricted sulfotransferase is expressed in rheumatoid arthritis synovium and is induced by lymphotoxin-α/ β and TNF-α in cultured endothelial cells. BMC Immunol., 2005, 6(1), 6.
79. Frezza, M.; Gorji, N.; Melato, M. The histopathology of nonsteroidal anti-inflammatory drug induced gastroduodenal damage: correlation with Helicobacter py lori, ulcers, and haemorrhagic events. J. Clin. Pathol., 2001, 54(7), 521-525.
80. Ota, H.; Katsuyama, T.; Ishii, K.; Nakayama, J.; Shiozawa, T.; Tsukahara, Y. A dual staining method for identifying mucins of different gastric epithelial mucous cells. Histochem. J., 1991, 23(1), 22-28.
81. Reis, C.A.; David, L.; Carvalho, F.; Mandel, U.; de Bolos, C.; Mirgorodskaya, E.; Clausen, H.; Sobrinho-Simoes, M. Immunohistochemical study of the expression of MUC6 mucin and co-expression of other secreted mucins (MUC5AC and MUC2) in human gastric carcinomas. J. Histochem. Cytochem., 2000, 48(3), 377-388.
82. Hidaka, E.; Ota, H.; Hidaka, H.; Hayama, M.; Matsuzawa, K.; Akamatsu, T.; Nakayama, J.; Katsuyama, T. Helicobacter pylori and two ultrastructurally distinct layers of gastric mucous cell mucins in the surface mucous gel layer. Gut, 2001, 49(4), 474-480.
83. Kawakubo, M.; Ito, Y.; Okimura, Y.; Kobayashi, M.; Sakura, K.; Kasama, S.; Fukuda, M.N.; Fukuda, M.; Katsuyama, T.; Nakayama, J. Natural antibiotic function of a human gastric mucin against Helicobacter p ylori infection. Science, 2004, 305(5686), 1003-1006.
84. Deutscher, S.L.; Nuwayhid, N.; Stanley, P.; Briles, E.I.; Hirschberg, C.B. Translocation across Golgi vesicle membranes: a CHO glycosylation mutant deficient in CMP-sialic acid transport. Cell, 1984, 39(2), 295-299.
85. Horii, T.; Mase, K.; Suzuki, Y.; Kimura, T.; Ohta, M.; Maekawa, M.; Kanno, T.; Kobayashi, M. Antibacterial activities of β-lactamase inhibitors associated with morphological changes of cell wall in Helicobacter pylori. Helicobacter, 2002, 7(1), 39-45.
86. Hirai, Y.; Haque, M.; Yoshida, T.; Yokota, K.; Yasuda, T.; Oguma, K. Unique cholesteryl glucosides in Helicobacter pylori: composition and structural analysis. J. Bacteriol., 1995, 177(18), 5327-5333.
87. Nakayama, J.; Yeh, J.C.; Misra, A.K.; Ito, S.; Katsuyama, T.; Fukuda, M. Expression cloning of a human α1,4-N-acetylglucosaminyltransferase that forms GlcNAcα1→4Galβ→R, a glycans specifically expressed in the gastric gland mucous cell-type mucin. Proc. Natl. Acad. Sci. USA, 1999, 96(16), 8991-8996.
88. Craanen, M.E.; Blok, P.; Dekker, W.; Ferwerda, J.; Tytgat, G.N. Subtypes of intestinal metaplasia and Helicobacter pylori. Gut, 1992, 33(5), 597-600.
89. Teixeira, A.; David, L.; Reis, C.A.; Costa, J.; Sobrinho-Simoes, M. Expression of mucins (MUC1, MUC2, MUC5AC, and MUC6) and type 1 Lewis antigens in cases with and without Helicobacter pylori colonization in metaplastic glands of the human stomach. J. Pathol., 2002, 197(1), 37-43.
90. Ferreira, B.; Marcos, N.T.; David, L.; Nakayama, J.; Reis, C.A. Terminal α1,4-linked N-acetylglucosamine in Helicobacter pylori- associated intestinal metaplasia of the human stomach and gastric carcinoma cell lines. J. Histochem. Cytochem., 2006, 54(5), 585-591.
91. Haque, M; Hirai, Y.; Yokota, K.; Mori, N.; Jahan, I.; Ito, H.; Hotta, H.; Yano, I.; Kanemasa, Y.; Oguma, K. Lipid profile of Helicobacter spp.: presence of cholesteryl glucoside as a characteristic feature. J. Bacteriol., 1996, 178(7), 2065-2070.
92. Wunder, C.; Churin, Y.; Winau, F.; Warnecke, D.; Vieth, M.; Lindner, B.; Zahringer, U.; Mollenkopf, H.J.; Heinz, E.; Meyer, T.F. Cholesterol glucosylation promotes immune evasion by Helicobacter pylori. Nat. Med., 2006, 12(9), 1030-1038.
93. Lee, H.; Kobayashi, M.; Wang, P.; Nakayama, J.; Seeberger, P.H.; Fukuda, M. Expression cloning of cholesterol α-glucosyltransferase, a unique enzyme that can be inhibited by natural antibiotic gastric mucin O-glycans, from Helicobacter pylori. Biochem. Biophys. Res. Commun., 2006, 349(4), 1235-1241.
94. Lebrun, A.H.; Wunder, C.; Hildebrand, J.; Churin, Y.; Zahringer, U.; Lindner, B.; Meyer, T.F.; Heinz, E.; Warnecke, D. Cloning of a cholesterol-α-glucosyltransferase from Helicobacter pylori. J. Biol. Chem., 2006, 281(38), 27765-27772.
95. Warnecke, D.; Erdmann, R.; Fahl, A.; Hube, B.; Muller, F.; Zank, T.; Zahringer, U.; Heinz, E. Cloning and functional expression of UGT genes encoding sterol glucosyltransferases from Saccharomyces cerevisiae, Candida albicans, Pichia pastoris, and Dictyostelium discoideum. J. Biol. Chem., 1999, 274(19), 13048-13059.
96. Fox, J.G.; Dewhirst, F.E.; Tully, J.G.; Paster, B.J.; Yan, L.; Taylor, N.S.; Collins, M.J., Jr.; Gorelick, P.L.; Ward, J.M. Helicobacter hepaticus sp. nov., a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice. J. Clin. Microbiol., 1994, 32(5), 1238-1245.
97. Andrutis, K.A.; Fox, J.G.; Schauer, D.B.; Marini, R.P.; Li, X.; Yan, L.; Josenhans, C.; Suerbaum, S. Infection of the ferret stomach by isogenic flagellar mutant strains of Helicobacter mustelae. Infect. Immun., 1997, 65(5), 1962-1966.
98. Eppinger, M.; Baar, C.; Linz, B.; Raddatz, G.; Lanz, C.; Keller, H.; Morelli, G.; Gressmann, H.; Achtman, M.; Schuster, S.C. Who ate whom? Adaptive Helicobacter genomic changes that accompanied a host jump from early humans to large felines. PloS Genet., 2006, 2(7), e120.
99. Taniguchi, N.; Honke, K.; Fukuda, M. Eds. Handbook of Glycosyl-transferases and Related Genes; Springer: Tokyo, 2001.
100. Lee, H.; Wang, P.; Hoshino, H.; Ito, Y.; Kobayashi, M.; Nakayama, J.; Seeberger, P.H.; Fukuda, M. α1,4GlcNAc-capped mucin-type O-glycan inhibits cholesterol α-glucosyltransferase from Helicobacter pylori and suppresses H. pylori growth. Glycobiology, 2008, 18(7), 549-558.
101. Capon, C.; Laboisse, C.L.; Wieruszeski, J.M.; Maoret, J.J.; Augeron, C.; Fournet, B. Oligosaccharide structures of mucins secreted by the human colonic cancer cell line CL.16E. J. Biol. Chem., 1992, 267(27), 19248-19257.
102. Lloyd, K.O.; Burchell, J.; Kudryashov, V.; Yin, B.W.; Taylor- Papadimitriou, J. Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines. Demonstration of simpler and fewer glycan chains in tumor cells. J. Biol. Chem., 1996, 271(52), 33325-33334.